Oncology

                   

Targeted cancer drugs boost success rates

pharmiweb.co.uk
4 hrs ago 3 related
        

Tuesday , November 18, 2008 Targeted cancer drugs like Herceptin and Glivec have greatly improved pharma's oncology pipeline success rates, according to a new study. Scientists from Cancer Research found cancer drugs now have...

add comment
                   

YM BIOSCIENCES INC.: Notice of YM Biosciences Annual and Special Meeting

finanznachrichten.de
8 hrs ago 8 related
        

Notice of YM Biosciences Annual and Special Meeting of Shareholders MISSISSAUGA, ON, Nov. 17 /CNW/ - YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and...

add comment
                   

World's Top Cancer Research Body Sponsors Landmark COLD-FX® Trial

bioresearchonline.com
2 hrs ago 5 related
        

CV Technologies Inc. recently announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients - the first time the natural medicine...

add comment

Thallion Initiates Enrollment in Phase II Metastatic Melanoma Trial

marketwire.com
2 hrs ago 2 related
        

MONTREAL, QUEBEC--(Marketwire - Nov. 18, 2008) - Thallion Pharmaceuticals Inc. (TSX:TLN) today announced that the first patient has been enrolled in its Phase II trial evaluating TLN-232 as a treatment for metastatic melanoma...

add comment
                   

Encorium Group Signs $6.5 Million of New Business Contracts Mainly Consisting of Oncology...

yahoo.com
54 mins ago 1 related
        

Tuesday November 18, 8:00 am ET Approximately $26 Million of New Business Contracts Announced During Past 4.5 Months WAYNE, Pa., Nov. 18 /PRNewswire-FirstCall/ -- News ), a full-service multinational contract research...

add comment

Aspirus oncologists to offer care in Point

wausaudailyherald.com
5 hrs ago
        

By Amy Olson • Wausau Daily Herald • November 18, 2008 STEVENS POINT -- Oncologists from the Aspirus Regional Cancer Center will begin providing cancer consultations and follow-up visits at the Aspirus Stevens Point Clinic...

add comment

Cancer Screening: The Clash of Medical Science and Intuition

nih.gov
16 hrs ago
        

NIH Clinical Center's 2008 Medicine for the Public Lecture Series The notion that early detection saves lives seems a simple and obvious truth, but many generally-accepted cancer-screening procedures have yet to be proven...

add comment
                   

First Pivotal Trials Begin For Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor...

medicalnewstoday.com
yesterday 7 related
        

Boehringer Ingelheim has marked a new milestone within its rapidly expanding oncology portfolio with the announcement today that the company has progressed another of its oncology compounds into pivotal phase III clinical...

add comment
pharmiweb.co.uk: Genetic Engineering pharmiweb.co.uk

Provectus Pharmaceuticals Adds Sixth Center to Phase 2 Clinical Trialof PV-10

pharmiweb.co.uk
yesterday 4 related
        

News source: Business Wire Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the Company's lead...

add comment
                   
pharmiweb.co.uk: Genetic Engineering pharmiweb.co.uk

Rexahn Pharmaceuticals Strengthens Clinical Development Leadershipwith Formation of Oncology...

pharmiweb.co.uk
yesterday 2 related
        

Rexahn Pharmaceuticals Strengthens Clinical Development Leadershipwith Formation of Oncology Scientific Advisory Board News source: Business Wire Rexahn Pharmaceuticals, Inc. , a leader in innovative therapeutics for...

add comment
1 2 3 4 5 next »